Bring your innovation to its destination

with creative analytical solutions that advance your path to commercialization

Research
Preclinical
Early-phase Clinical
Late-phase Clinical
Commercial

Article: CSO Danny Galbraith, PhD shares his insights with Drug Target Review.

Read More
decorative roadmap graphic

Deep CMC testing expertise across
the pharmaceutical spectrum

Biologics

Extensive expertise in analyzing sophisticated large molecule drugs.

Cell & Gene Therapies

Specialized expertise in analysis for next-generation therapies.

Small Molecules

Comprehensive testing capabilities across a wide range of compounds.

decorative roadmap graphic

One partner for your entire
drug development journey

Cell-Based Bioassays

Analytical Method Development & Validation

Analytical Characterization Services

cGMP Drug Substance & Drug Product Testing & Release

Let’s advance your development project

175 +
PhD-level scientists
800 +
team members in Europe & U.S.
700 +
customers worldwide
19
of the top 20 pharma companies choose Solvias
decorative roadmap graphic

Latest News & Insights

Press Releases
Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy

Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy

Read More
White Papers
The True Cost of Inadequate Extractables & Leachables Testing

The True Cost of Inadequate Extractables & Leachables Testing

Read More